Recursion Pharmaceuticals, Inc. (RXRX)

3.42 -0.30 (-8.06%) USD  |  NASDAQ  |  Feb 20, 16:00
3.36 -0.06 (-1.75%) Pre-Market: 09:24
More

Recursion Pharmaceuticals Ending Cash (Quarterly)

Ending Cash (Quarterly) Chart

View Ending Cash (Quarterly) for RXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Ending Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Ending Cash (Quarterly) Range, Past 5 Years

View Ending Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Ending Cash (Quarterly) Benchmarks

View Ending Cash (Quarterly) Benchmarks
Start Trial
Hims & Hers Health, Inc. Upgrade
Intellia Therapeutics, Inc. Upgrade
XOMA Royalty Corp. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade